


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app19.us.archive.org';v.server_ms=698;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>ACR Appropriateness Criteria&amp;reg; chronic extremity joint pain&amp;mdash;suspected inflammatory arthritis. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712202903im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712202903im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712202903im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712202903im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712202903/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712202903im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712202903cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712202903js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712202903if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712202903/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712202903if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712202903/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712202903/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712202903/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712202903/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712202903/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712202903/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712202903/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712202903/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712202903/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712202903/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712202903/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712202903/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712202903/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712202903/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712202903/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712202903/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712202903/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712202903/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712202903/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712202903/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712202903/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712202903/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712202903/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712202903/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712202903/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:011079</li>
            <li>2016
            </li>            
                                </ul>
        <div>
                <h1>ACR Appropriateness Criteria&reg; chronic extremity joint pain&mdash;suspected inflammatory arthritis.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712202903/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20College%20of%20Radiology&amp;fLockTerm=American%2BCollege%2Bof%2BRadiology">American College of Radiology</a></li>
                        <li>   
                                <a id="246" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Jacobson JA, Roberts CC, Bencardino JT, Appel M, Arnold E, Baccei SJ, Cassidy RC, Chang EY, Fox MG, Greenspan BS, Gyftopoulos S, Hochman MG, Mintz DN, Newman JS, Rosenberg ZS, Shah NA, Small KM, Weissman BN, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® chronic extremity joint pain–suspected inflammatory arthritis. Reston (VA): American College of Radiology (ACR); 2016. 11 p.  [45 references]</td></tr></table>                    <p><a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=fulltextlink&amp;redirect=https%253a%252f%252facsearch.acr.org%252fdocs%252f3097211%252fNarrative%252f">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                            <h4>UMLS Concepts <a href="/web/20180712202903/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712202903/https://www.guideline.gov/search?f_ICD9CM_CUI=C0018099&amp;fLockTerm=Gout%2c+unspecified">Gout, unspecified</a>
 (274.9), <a href="/web/20180712202903/https://www.guideline.gov/search?f_ICD9CM_CUI=C0003862&amp;fLockTerm=Pain+in+joint%2c+site+unspecified">Pain in joint, site unspecified</a>
 (719.40), <a href="/web/20180712202903/https://www.guideline.gov/search?f_ICD9CM_CUI=C0003873&amp;fLockTerm=Rheumatoid+arthritis">Rheumatoid arthritis</a>
 (714.0)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0003862&amp;fLockTerm=Arthralgia">Arthralgia</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0003864&amp;fLockTerm=Arthritis">Arthritis</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0003873&amp;fLockTerm=Arthritis%2c+Rheumatoid">Arthritis, Rheumatoid</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0150055&amp;fLockTerm=Chronic+Pain">Chronic Pain</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F18">Fluorodeoxyglucose F18</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0018099&amp;fLockTerm=Gout">Gout</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0024485&amp;fLockTerm=Magnetic+Resonance+Imaging">Magnetic Resonance Imaging</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0029408&amp;fLockTerm=Osteoarthritis">Osteoarthritis</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0032743&amp;fLockTerm=Positron-Emission+Tomography">Positron-Emission Tomography</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C1962945&amp;fLockTerm=Radiography">Radiography</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0034606&amp;fLockTerm=Radionuclide+Imaging">Radionuclide Imaging</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0949691&amp;fLockTerm=Spondylarthropathies">Spondylarthropathies</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0039411&amp;fLockTerm=Technetium">Technetium</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0936234&amp;fLockTerm=Tomography+Scanners%2c+X-Ray+Computed">Tomography Scanners, X-Ray Computed</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0040405&amp;fLockTerm=Tomography%2c+X-Ray+Computed">Tomography, X-Ray Computed</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MSH_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0003862&amp;fLockTerm=Arthralgia">Arthralgia</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0003864&amp;fLockTerm=Arthritis">Arthritis</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0856830&amp;fLockTerm=Calcium+pyrophosphate+arthropathy">Calcium pyrophosphate arthropathy</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0150055&amp;fLockTerm=Chronic+pain">Chronic pain</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0936234&amp;fLockTerm=Computed+Tomography+Scanning+Systems">Computed Tomography Scanning Systems</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0029408&amp;fLockTerm=Degenerative+polyarthritis">Degenerative polyarthritis</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0043299&amp;fLockTerm=Diagnostic+radiologic+examination">Diagnostic radiologic examination</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F18">Fluorodeoxyglucose F18</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0018099&amp;fLockTerm=Gout">Gout</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0024485&amp;fLockTerm=Magnetic+Resonance+Imaging">Magnetic Resonance Imaging</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0032743&amp;fLockTerm=Positron-Emission+Tomography">Positron-Emission Tomography</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C1962945&amp;fLockTerm=Radiographic+imaging+procedure">Radiographic imaging procedure</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0034606&amp;fLockTerm=Radionuclide+Imaging">Radionuclide Imaging</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0003873&amp;fLockTerm=Rheumatoid+Arthritis">Rheumatoid Arthritis</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0949691&amp;fLockTerm=Spondylarthropathies">Spondylarthropathies</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0039411&amp;fLockTerm=Technetium">Technetium</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_MTH_CUI=C0040405&amp;fLockTerm=X-Ray+Computed+Tomography">X-Ray Computed Tomography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712202903/https://www.guideline.gov/search?f_PDQ_CUI=C0040405&amp;fLockTerm=computed+tomography">computed tomography</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_PDQ_CUI=C0043299&amp;fLockTerm=diagnostic+radiology">diagnostic radiology</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_PDQ_CUI=C0046056&amp;fLockTerm=fludeoxyglucose+F+18">fludeoxyglucose F 18</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_PDQ_CUI=C0024485&amp;fLockTerm=magnetic+resonance+imaging">magnetic resonance imaging</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_PDQ_CUI=C0034606&amp;fLockTerm=radionuclide+imaging">radionuclide imaging</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_PDQ_CUI=C0041618&amp;fLockTerm=ultrasonography">ultrasonography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0303612&amp;fLockTerm=%5e99%5eTechnetium">^99^Technetium</a>
 (76743004), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003864&amp;fLockTerm=Arthritis">Arthritis</a>
 (3723001), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0150055&amp;fLockTerm=Chronic+pain">Chronic pain</a>
 (82423001), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040405&amp;fLockTerm=Computerized+axial+tomography">Computerized axial tomography</a>
 (77477000), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (385420005), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (407935004), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0029408&amp;fLockTerm=Degenerative+polyarthritis">Degenerative polyarthritis</a>
 (225655006), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0029408&amp;fLockTerm=Degenerative+polyarthritis">Degenerative polyarthritis</a>
 (396275006), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0949691&amp;fLockTerm=Disorder+of+joint+of+spine">Disorder of joint of spine</a>
 (372109003), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F%5e18%5e">Fluorodeoxyglucose F^18^</a>
 (35321007), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0018099&amp;fLockTerm=Gout">Gout</a>
 (90560007), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003862&amp;fLockTerm=Joint+pain">Joint pain</a>
 (57676002), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0024485&amp;fLockTerm=Magnetic+resonance+imaging">Magnetic resonance imaging</a>
 (113091000), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0024485&amp;fLockTerm=Magnetic+resonance+imaging">Magnetic resonance imaging</a>
 (312250003), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0336660&amp;fLockTerm=Magnetic+resonance+imaging+unit">Magnetic resonance imaging unit</a>
 (90003000), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0034606&amp;fLockTerm=Nuclear+medicine+imaging+procedure">Nuclear medicine imaging procedure</a>
 (373205008), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032743&amp;fLockTerm=Positron+emission+tomography">Positron emission tomography</a>
 (363678002), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032743&amp;fLockTerm=Positron+emission+tomography">Positron emission tomography</a>
 (82918005), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0182349&amp;fLockTerm=Positron+emission+tomography+unit">Positron emission tomography unit</a>
 (39821008), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0182349&amp;fLockTerm=Positron+emission+tomography+unit">Positron emission tomography unit</a>
 (462323006), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1962945&amp;fLockTerm=Radiographic+imaging+procedure">Radiographic imaging procedure</a>
 (363680008), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003873&amp;fLockTerm=Rheumatoid+arthritis">Rheumatoid arthritis</a>
 (69896004), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0410574&amp;fLockTerm=Synovial+hypertrophy">Synovial hypertrophy</a>
 (240206002), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0039411&amp;fLockTerm=Technetium">Technetium</a>
 (71789007), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
 (16310003), <a href="/web/20180712202903/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
 (278292003)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180712202903/https://www.guideline.gov/search?f_SPN_CUI=C0302622&amp;fLockTerm=SYSTEM%2c+IMAGING%2c+PULSED+DOPPLER%2c+ULTRASONIC">SYSTEM, IMAGING, PULSED DOPPLER, ULTRASONIC</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_SPN_CUI=C0336660&amp;fLockTerm=SYSTEM%2c+NUCLEAR+MAGNETIC+RESONANCE+IMAGING">SYSTEM, NUCLEAR MAGNETIC RESONANCE IMAGING</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_SPN_CUI=C0182349&amp;fLockTerm=SYSTEM%2c+TOMOGRAPHY%2c+COMPUTED%2c+EMISSION">SYSTEM, TOMOGRAPHY, COMPUTED, EMISSION</a>
, <a href="/web/20180712202903/https://www.guideline.gov/search?f_SPN_CUI=C0936234&amp;fLockTerm=SYSTEM%2c+X-RAY%2c+TOMOGRAPHY%2c+COMPUTED">SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712202903/https://www.guideline.gov/search?f_UMD_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
 (16-573), <a href="/web/20180712202903/https://www.guideline.gov/search?f_UMD_CUI=C0492899&amp;fLockTerm=Radiographic+Systems">Radiographic Systems</a>
 (18-429), <a href="/web/20180712202903/https://www.guideline.gov/search?f_UMD_CUI=C0936234&amp;fLockTerm=Scanning+Systems%2c+Computed+Tomography">Scanning Systems, Computed Tomography</a>
 (13-469), <a href="/web/20180712202903/https://www.guideline.gov/search?f_UMD_CUI=C1139717&amp;fLockTerm=Scanning+Systems%2c+Computed+Tomography%2fPositron+Emission+Tomography">Scanning Systems, Computed Tomography/Positron Emission Tomography</a>
 (20-161), <a href="/web/20180712202903/https://www.guideline.gov/search?f_UMD_CUI=C0336660&amp;fLockTerm=Scanning+Systems%2c+Magnetic+Resonance+Imaging">Scanning Systems, Magnetic Resonance Imaging</a>
 (16-260), <a href="/web/20180712202903/https://www.guideline.gov/search?f_UMD_CUI=C0182349&amp;fLockTerm=Scanning+Systems%2c+Positron+Emission+Tomography">Scanning Systems, Positron Emission Tomography</a>
 (16-375), <a href="/web/20180712202903/https://www.guideline.gov/search?f_UMD_CUI=C0302622&amp;fLockTerm=Scanning+Systems%2c+Ultrasonic">Scanning Systems, Ultrasonic</a>
 (14-278)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/downloadcontent/ngc-11079?contentType=pdf" class="pdf">.PDF 129.7 kb</a></li>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/downloadcontent/ngc-11079?contentType=word" class="word">Word Document 346.7 kb</a></li>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/downloadcontent/ngc-11079?contentType=xml" class="xml">.XML 93.9 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712202903/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/50494/acr-appropriateness-criteria--chronic-extremity-joint-pain-suspected-inflammatory-arthritis" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712202903/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/50494/acr-appropriateness-criteria--chronic-extremity-joint-pain-suspected-inflammatory-arthritis" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712202903/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/50494/acr-appropriateness-criteria--chronic-extremity-joint-pain-suspected-inflammatory-arthritis&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712202903/mailto:/?Subject=AHRQ: ACR Appropriateness Criteria&amp;amp;reg; chronic extremity joint pain&amp;amp;mdash;suspected inflammatory arthritis.&amp;body=https://www.guideline.gov/summaries/summary/50494/acr-appropriateness-criteria--chronic-extremity-joint-pain-suspected-inflammatory-arthritis" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: ACR Appropriateness Criteria&reg; chronic extremity joint pain&mdash;suspected inflammatory arthritis. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2016 Jan 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/citedownload/50494?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/citedownload/50494?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/citedownload/50494?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/citedownload/50494?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/citedownload/50494?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/citedownload/50494">RefWorks</a></li>
                            <li><a href="/web/20180712202903/https://www.guideline.gov/summaries/citedownload/50494?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="50494" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">ACR Appropriateness Criteria&reg;</span></strong></p>
<p><strong><span style="text-decoration: underline;">Clinical Condition</span>: Chronic Extremity Joint Pain&mdash;Suspected Inflammatory Arthritis</strong></p>
<p><strong><span style="text-decoration: underline;">Variant 1</span>: Chronic extremity joint pain. Suspect rheumatoid arthritis.</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Variant 1: Chronic extremity joint pain. Suspect rheumatoid arthritis.">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">X-ray appendicular skeleton area of interest</td>
            <td class="Center" valign="top">9</td>
            <td valign="top">This procedure is the initial imaging method.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">MRI appendicular skeleton area of interest without IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">This procedure complements x-ray.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI appendicular skeleton area of interest without and with IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">This procedure complements x-ray.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">US appendicular skeleton area of interest</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">This procedure complements x-ray.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest without IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest with IV contrast</td>
            <td class="Center" valign="top">3</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">Tc-99m bone scan whole body </td>
            <td valign="top" style="text-align: center;">2</td>
            <td valign="top">&nbsp;</td>
            <td valign="top" style="text-align: center;"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest without and with IV contrast</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the table are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 2</span>: Chronic extremity joint pain. Suspect seronegative spondyloarthropathy.</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Variant 2: Chronic extremity joint pain. Suspect seronegative spondyloarthropathy.">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">X-ray appendicular skeleton area of interest</td>
            <td class="Center" valign="top">9</td>
            <td valign="top">This procedure is the initial imaging method.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">MRI appendicular skeleton area of interest without and with IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">This procedure complements x-ray.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">US appendicular skeleton area of interest </td>
            <td class="Center" valign="top">7</td>
            <td valign="top">This procedure complements x-ray.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI appendicular skeleton area of interest without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest without IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest with IV contrast</td>
            <td class="Center" valign="top">3</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest without and with IV contrast</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">Tc-99m bone scan whole body </td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the table are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 3</span>: Chronic extremity joint pain. Suspect gout.</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Variant 3: Chronic extremity joint pain. Suspect gout.">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">X-ray appendicular skeleton area of interest</td>
            <td class="Center" valign="top">9</td>
            <td valign="top">This procedure is the initial imaging method.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest without IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">This refers specifically to dual-energy CT and complements x-ray.</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">US appendicular skeleton area of interest</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">This procedure complements x-ray.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI appendicular skeleton area of interest without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI appendicular skeleton area of interest without and with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest with IV contrast</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">CT appendicular skeleton area of interest without and with IV contrast</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">Tc-99m bone scan whole body </td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the table are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 4</span>: Chronic extremity joint pain. Suspect calcium pyrophosphate dihydrate disease (pseudogout).</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Variant 4: Chronic extremity joint pain. Suspect calcium pyrophosphate dihydrate disease (pseudogout).">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">X-ray area of interest</td>
            <td class="Center" valign="top">9</td>
            <td valign="top">This procedure shows characteristic findings.</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">CT area of interest without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">MRI area of interest without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI area of interest without and with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">US area of interest </td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT area of interest with IV contrast</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">CT area of interest without and with IV contrast</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">Tc-99m bone scan whole body</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the table are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 5</span>: Chronic extremity joint pain. Suspect erosive osteoarthritis.</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Variant 5: Chronic extremity joint pain. Suspect erosive osteoarthritis.">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">X-ray area of interest</td>
            <td class="Center" valign="top">9</td>
            <td valign="top">This procedure shows characteristic findings.</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">MRI area of interest without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI area of interest without and with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">US area of interest </td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT area of interest without IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">CT area of interest with IV contrast</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">CT area of interest without and with IV contrast</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">Varies</td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
        <tr>
            <td valign="top">Tc-99m bone scan whole body</td>
            <td class="Center" valign="top">1</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the table are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Summary of Literature Review</span></strong></p>
<p><strong>Introduction/Background</strong></p>
<p>In the evaluation for suspected inflammatory arthritis, it is critical that imaging results are interpreted in the context of clinical and serologic results to add specificity as there is significant overlap of imaging findings amongst the various types of arthritis. In addition, many of the imaging findings at one articulation are not specific for one disease process and do not provide the overall diagnosis; therefore, other factors such as global distribution of joint involvement as well as findings from other imaging modalities remain essential to provide an accurate diagnosis. In general, imaging is used to identify abnormalities of osseous and/or soft tissues that can indicate the presence of a chronic inflammatory arthritis.</p>
<p><strong>Overview of Imaging Modalities</strong></p>
<p><em>Osseous Abnormalities</em></p>
<p>In addition to joint space narrowing, the osseous abnormalities of the extremities that are assessed include erosions and bone proliferation. Erosions, which appear as cortical discontinuity, may be seen at the margins of synovial joints (rheumatoid arthritis and spondyloarthropathies), periarticular (gout), central (erosive osteoarthritis), and at the enthesis (spondyloarthropathies). Bone proliferation, in the form of periostitis and enthesitis, is a hallmark of the spondyloarthropathies and may occur at any cortical bone, including both tendon and ligament attachments. Imaging of osseous abnormalities typically begins with radiography. Although specific, radiography has somewhat low sensitivity given the degree of overlap of the osseous structures. Multiple radiographic views of a joint are often needed to improve erosion identification, such as the hands (posteroanterior, oblique, lateral, semisupinated) and the sacroiliac joints (angled anteroposterior and oblique). Using computed tomography (CT) as the standard of reference, which is an ideal imaging method to characterize cortical bone abnormalities, radiography has 19% sensitivity, 100% specificity, and 81% accuracy in the diagnosis of erosions of the metacarpophalangeal joints. Another technique called tomosynthesis is similar to conventional tomography and can show more erosions than routine radiography.</p>
<p>Ultrasound (US) has been used to evaluate for osseous abnormalities in the setting of chronic inflammatory arthritis as well. Compared with radiography, US has been shown to demonstrate a 6.5-fold increase in number of detected erosions of the metacarpophalangeal joints. However, compared with CT, US was able to identify only 42% of erosions in the metacarpophalangeal joints, with a specificity of 92% and an accuracy of 87%. In addition, the false-positive rate for US in detection of metacarpophalangeal joint erosions has been reported as high as 29%. Regardless, large erosions identified with US at the second and third metacarpophalangeal joints, the distal ulna, and the fifth metatarsophalangeal joint are highly specific for and predictive of rheumatoid arthritis.</p>
<p>Magnetic resonance imaging (MRI) can be also used to identify cortical erosions and provide a comprehensive overview of a disease process. Technical factors and image resolution remain important, as imaging parameters and slice thickness must be optimized to identify erosions. One study evaluating the wrist in rheumatoid arthritis showed that MRI outperformed radiography in the diagnosis of erosions, with MRI identifying erosions in 45% of patients compared with 15% on radiography. Another study comparing MRI and US with CT showed that sensitivities for diagnosis of erosions were 68% and 42%, respectively. However, a meta-analysis concluded that both US and MRI were of comparable efficacy in the detection of erosions.</p>
<p><em>Soft-tissue Abnormalities</em></p>
<p>The soft-tissue abnormalities of the extremities that are assessed with imaging include synovial hypertrophy, which may involve the recesses of synovial joints, tendon sheaths, and bursae, as well as tophi. Radiography and to a lesser extent CT are insensitive in the evaluation of synovial hypertrophy. However, both US and MRI ideally show synovial hypertrophy and can detect hyperemia and enhancement, respectively, to indicate inflammation and severity of synovitis. Both US and MRI outperform clinical examination in the diagnosis of synovitis. In addition, decreased synovial thickness and decreased hyperemia or enhancement can indicate a positive response to therapy and can guide the decision to continue or change treatment. In the diagnosis of synovitis of the fingers, US has been shown to outperform contrast-enhanced MRI. However, another more recent study has shown that MRI with intravenous gadolinium is more sensitive than US and has a higher diagnostic performance, especially in the early stages of rheumatoid arthritis.</p>
<p>With regard to nuclear medicine in the evaluation of inflammatory arthritis, Tc-99m scintigraphy has been shown to be sensitive but not specific in the diagnosis of inflammatory arthritis, but it can detect inflammation and predict cortical erosions. When adding single-photon emission CT (SPECT), rheumatoid arthritis could be differentiated from osteoarthritis given the added information from tomographic images. Similarly, fluorine-18-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) uptake can be seen at sites of inflammation but can be limited by being nonspecific.</p>
<p>In the evaluation of the soft tissues in crystal deposition diseases, imaging can also be used to identify intra-articular crystal deposition and chondrocalcinosis, as well as calcification of other structures, such as tendon and capsule, in the setting of calcium pyrophosphate dihydrate disease, or pseudogout. Such calcifications can be visualized by radiography, US, and CT, whereas MRI is less sensitive. With regard to soft-tissue tophi associated with gout, radiography and routine CT may show a tophus as increased opacity and increased attenuation, respectively. Although MRI is sensitive in detection of tophi, US shows characteristic features. Dual-energy CT has been also used to detect and quantify monosodium urate crystals in gout with a high degree of sensitivity and accuracy. Imaging-guided joint aspiration and synovial biopsy can also be considered to confirm crystal deposition disease.</p>
<p><strong>Discussion of Imaging Modalities by Variant</strong></p>
<p><em>Variant 1: Chronic Extremity Joint Pain. Suspect Rheumatoid Arthritis</em></p>
<p><span style="text-decoration: underline;">Radiography</span></p>
<p>The hallmarks of rheumatoid arthritis on radiography include periarticular osteopenia, uniform joint space narrowing, and osseous erosions. Although erosions occur later in the disease course, radiography remains important to identify possible erosions and provide an overview of distribution of disease that involves the extremities, and it is recommended as the initial imaging method.</p>
<p><span style="text-decoration: underline;">Computed Tomography</span></p>
<p>CT, although more sensitive in detection of erosions compared with radiography and MRI, is not routinely used and is limited in the ability to show synovial hypertrophy and other soft-tissue abnormalities.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging</span></p>
<p>MRI with intravenous gadolinium has been shown to be more sensitive compared with US and has a higher diagnostic performance, especially in the early stages of rheumatoid arthritis. However, when comparing MRI and US, the evidence is inconclusive as to which imaging method should be considered for evaluation of rheumatoid arthritis. Both MRI and US outperform clinical evaluation in the detection of inflammation and structural damage and provide prognostic information concerning progression. Imaging findings that predict progression of disease include bone marrow edema and synovitis. The use of intravenous gadolinium is important for detection of synovitis and tenosynovitis but is less important in detection of osseous erosions.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US outperforms clinical evaluation in detection of inflammation and structural damage of rheumatoid arthritis. In addition, US provides prognostic information (such as detecting synovitis) that is linked to progression. In evaluation of seronegative inflammatory arthritis with US, the presence of erosions, synovial hypertrophy, and hyperemia on US increase the post-test probability of inflammatory arthritis to 50% to 94%. Mild synovial hypertrophy as an isolated finding is not specific and has limited relevance. In evaluation of the finger joints with US, dorsal evaluation is recommended over palmar. Abbreviated US scanning protocols of the hands, wrists, and feet to improve efficiency have been described. When comparing US and MRI, the evidence is inconclusive as to which imaging method should be considered for evaluation of rheumatoid arthritis.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>FDG-PET/CT is not routinely used in the evaluation of rheumatoid arthritis.</p>
<p><span style="text-decoration: underline;">Bone Scan</span></p>
<p>Bone scans are not routinely used in the evaluation of rheumatoid arthritis. </p>
<p><em>Variant 2: Chronic Extremity Joint Pain. Suspect Seronegative Spondyloarthropathy</em></p>
<p>Imaging assessment for the seronegative spondyloarthropathies, which include psoriatic arthritis, reactive arthritis, ankylosing spondylitis, and arthritis associated with inflammatory bowel disease, includes the synovial spaces, entheses, and osseous surfaces of the extremities.</p>
<p><span style="text-decoration: underline;">Radiography</span></p>
<p>The findings of spondyloarthropathy related to erosions, enthesitis, and bone proliferation are well characterized by radiography.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US can identify synovial hypertrophy and blood flow on color Doppler imaging. Although US may also identify erosions and bone proliferation, US may be insensitive (as portions of osseous structures cannot be imaged) as well as not specific (bone irregularity from many causes may appear similar). US may also show imaging findings associated with enthesitis. An additional finding described at US is increased distance between the nail and distal phalanx in patients with psoriatic arthritis and cutaneous psoriasis with 80% sensitivity and 71% specificity.</p>
<p><span style="text-decoration: underline;">Computed Tomography</span></p>
<p>CT can be used to show cortical erosions, bone proliferation, and enthesitis but is not routinely used for this indication in the extremities. Soft-tissue abnormalities and synovitis are not well demonstrated.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging</span></p>
<p>MRI can show cortical erosions, as well as synovial hypertrophy and other soft-tissue abnormalities, with use of intravenous gadolinium. Cortical irregularity from enthesitis and periostitis may also be seen and can be associated with increased fluid signal; although often nonspecific, the location of findings at the entheses and distribution can suggest the diagnosis of seronegative spondyloarthropathy. Increased fluid signal may also be seen on MRI within the bone marrow subjacent to inflammatory enthesitis and periostitis.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>FDG-PET/CT is a sensitive imaging method in detection of enthesitis.</p>
<p><span style="text-decoration: underline;">Bone Scan</span></p>
<p>Bone scans are not routinely used in the evaluation of spondyloarthropathy.</p>
<p>For suspected seronegative spondyloarthropathy, evaluation of axial skeleton, see the National Guideline Clearinghouse (NGC) summary of the <a href="/web/20180712202903/https://www.guideline.gov/summaries/summary/50427/" title="Guideline #11034" target="_blank">ACR Appropriateness Criteria&reg; chronic back pain: suspected sacroiliitis/spondyloarthropathy</a>.</p>
<p><em>Variant 3: Chronic Extremity Joint Pain. Suspect Gout</em></p>
<p><span style="text-decoration: underline;">Radiography</span></p>
<p>Gout can involve the synovial spaces, showing joint distention due to effusion and synovial hypertrophy. Soft-tissue tophi, if not calcified, may appear nonspecific as focal increased opacity on radiography; however, adjacent characteristic erosions may be identified. Identification of erosions may prove difficult when located where osseous structures overlap.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>At US, intra-articular microtophi, echogenic synovial hypertrophy, and "icing" of the cartilage (the double contour sign) are characteristic. Using US, identification of the double contour sign and soft-tissue tophi results in sensitivities/specificities of 83%/76% and 65%/80%, respectively. US has been shown to outperform clinical assessment in the diagnosis of gout. Although US outperforms radiography in the detection of erosions, limitations exist if an erosion involves an area of bone that is inaccessible to US evaluation.</p>
<p><span style="text-decoration: underline;">Computed Tomography</span></p>
<p>Soft-tissue tophi, if not calcified, appear as focal increased attenuation on CT (160&ndash;170 Hounsfield units), often associated with a tendon or adjacent erosion. CT demonstrates characteristic osseous erosions and can show bone involvement in areas that are difficult to evaluate with radiography. Dual-energy CT has been used to show monosodium urate deposition with a sensitivity of 87% and specificity of 84%. However, dual-energy CT has been reported as inaccurate when evaluating the shoulder and hip. Dual-energy CT outperforms clinical assessment in the diagnosis of gout.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging</span></p>
<p>MRI can be used to demonstrate soft-tissue tophi with 63% sensitivity and 98% specificity in the diagnosis of chronic gouty arthropathy. MRI is more sensitive than US in detection of erosions, and both outperform radiography.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>FDG-PET/CT is not routinely used in the evaluation of gout.</p>
<p><span style="text-decoration: underline;">Bone Scan</span></p>
<p>Bone scans are not routinely used in the evaluation of gout.</p>
<p><em>Variant 4: Chronic Extremity Joint Pain. Suspect Calcium Pyrophosphate Dihydrate Disease (Pseudogout)</em></p>
<p><span style="text-decoration: underline;">Radiography</span></p>
<p>The hallmark of pseudogout is soft-tissue calcification in the form of chondrocalcinosis, as well as tendon, ligament, and capsular calcification. Radiography can be effective in demonstrating such calcifications in the extremities. Target sites to evaluate for fibrocartilage chondrocalcinosis include the triangular fibrocartilage of the wrists, the menisci of the knees, and the symphysis pubis and labrum at the pelvis, whereas involvement of the hyaline cartilage may occur at any joint. The osseous changes from associated arthropathy characteristically involve the radiocarpal, metacarpophalangeal, and patellofemoral joints and are well demonstrated by radiography.</p>
<p><span style="text-decoration: underline;">Computed Tomography</span></p>
<p>CT can identify chondrocalcinosis and calcification of tendons, ligaments, and joint capsules. The osseous changes related to pseudogout, such as arthropathy characteristically involving the radiocarpal, metacarpophalangeal, atlantoaxial, and patellofemoral joints, are also well demonstrated by CT.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging</span></p>
<p>MRI can demonstrate chondrocalcinosis with a higher sensitivity than radiography when using gradient-recalled echo sequences. MRI with intravenous gadolinium may also show synovial hypertrophy if present. The osseous changes related to pseudogout, such as arthropathy characteristically involving the radiocarpal, metacarpophalangeal, and patellofemoral joints, are well demonstrated by MRI.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US may show soft-tissue calcification as well as synovial hypertrophy. In the knee, the sensitivity/specificity in identification of calcium pyrophosphate dihydrate crystal deposition within the fibrocartilage and hyaline cartilage by US is reported as 90.5%/100% and 59%/100%, respectively, outperforming radiography.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>FDG-PET/CT is not routinely used in the evaluation of calcium pyrophosphate crystal deposition disease.</p>
<p><span style="text-decoration: underline;">Bone Scan</span></p>
<p>Bone scans are not routinely used in the evaluation of calcium pyrophosphate crystal deposition disease.</p>
<p><em>Variant 5: Chronic Extremity Joint Pain. Suspect Erosive Osteoarthritis</em></p>
<p><span style="text-decoration: underline;">Radiography</span></p>
<p>The characteristic central erosions involving the interphalangeal joints are well demonstrated by radiography.</p>
<p><span style="text-decoration: underline;">Computed Tomography</span></p>
<p>Similar to radiographs, the central erosions involving the interphalangeal joints are also demonstrated by CT.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>Although US may show synovial hypertrophy and marginal osteophytes, the characteristic central erosion of the interphalangeal joint is not visible. Both US and contrast-enhanced MRI have been shown to perform equally in the demonstration of synovitis of the fingers associated with erosive osteoarthritis.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging</span></p>
<p>MRI can show the features of erosive osteoarthritis, although the findings may be nonspecific, potentially mimicking other types of joint inflammation. Both US and contrast-enhanced MRI have been shown to perform equally in the demonstration of synovitis of the fingers associated with erosive osteoarthritis.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>FDG-PET/CT is not routinely used in the evaluation of erosive osteoarthritis.</p>
<p><span style="text-decoration: underline;">Bone Scan</span></p>
<p>Bone scans are not routinely used in the evaluation of erosive osteoarthritis. </p>
<p><strong><span style="text-decoration: underline;">Summary of Recommendations</span></strong></p>
<ul style="list-style-type: disc;">
    <li>Variant 1 (rheumatoid arthritis): Radiography should be the initial imaging method, often showing characteristic disease distribution and imaging findings. Both ultrasound and MRI complement radiography by showing synovitis and identifying additional erosions, although MRI may outperform ultrasound in early disease. </li>
    <li>Variant 2 (seronegative spondyloarthropathy): Radiography should be the initial imaging method, often showing characteristic osseous findings. Both ultrasound and MRI complement radiography by showing synovitis and identifying additional erosions. </li>
    <li>Variant 3 (gout): Radiography should be the initial imaging method as imaging findings are often characteristic. Both ultrasound and CT, including dual-energy CT, complement radiography in the detection of erosions and tophi. </li>
    <li>Variant 4 (pseudogout): Radiography should be the initial imaging method, often showing characteristic disease distribution and calcification. Both ultrasound and gradient-recalled echo MRI outperform radiography for chondrocalcinosis detection and complement radiography by showing synovitis and additional osseous findings. </li>
    <li>Variant 5 (erosive osteoarthritis): Radiography should be the initial imaging method, showing characteristic imaging findings. Both ultrasound and MRI complement radiography by showing synovitis. </li>
</ul>
<p><strong><strong>Abbreviations</strong></strong></p>
<ul style="list-style-type: disc;">
    <li>CT, computed tomography </li>
    <li>FDG-PET/CT, fluorine-18-2-fluoro-2-deoxy-D-glucose positron-emission tomography </li>
    <li>IV, intravenous </li>
    <li>MRI, magnetic resonance imaging </li>
    <li>Tc-99m, technetium-99 metastable </li>
    <li>US, ultrasound </li>
</ul>
<p><strong>Relative Radiation Level Designations</strong></p>
<table width="50%" border="1" cellspacing="3" cellpadding="5" summary="Table: Relative Radiation Level Designations">
    <thead>
        <tr>
            <th class="Center" valign="top">Relative Radiation Level*</th>
            <th class="Center" valign="top">Adult Effective Dose Estimate Range</th>
            <th class="Center" valign="top">Pediatric Effective Dose Estimate Range</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td class="Center" valign="top">O</td>
            <td class="Center" valign="top">0 mSv</td>
            <td class="Center" valign="top">0 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
            <td class="Center" valign="top">&lt;0.1 mSv</td>
            <td class="Center" valign="top">&lt;0.03 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
            <td class="Center" valign="top">0.1-1 mSv</td>
            <td class="Center" valign="top">0.03-0.3 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
            <td class="Center" valign="top">1-10 mSv</td>
            <td class="Center" valign="top">0.3-3 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
            <td class="Center" valign="top">10-30 mSv</td>
            <td class="Center" valign="top">3-10 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/> <img alt="radioactive symbol 5" src="https://web.archive.org/web/20180712202903im_/http://guideline.gov/images/image_radioactive.gif"/></td>
            <td class="Center" valign="top">30-100 mSv</td>
            <td class="Center" valign="top">10-30 mSv</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <td valign="top" colspan="3">*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as "Varies."</td>
    </tr>
    </tfoot>
</table></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>Algorithms were not developed from criteria guidelines.</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Chronic extremity joint pain caused by suspected inflammatory arthritis</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Diagnosis</p>
                    <p>Evaluation</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Internal Medicine</p>
                    <p>Nuclear Medicine</p>
                    <p>Radiology</p>
                    <p>Rheumatology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Health Plans</p>
                    <p>Hospitals</p>
                    <p>Managed Care Organizations</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                    <p>Students</p>
                    <p>Utilization Management</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To evaluate the appropriateness of imaging procedures for patients with chronic extremity joint pain caused by suspected inflammatory arthritis</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Patients with chronic extremity joint pain caused by suspected inflammatory arthritis</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;" start="1">
    <li>X-ray
    <ul style="list-style-type: disc;">
        <li>Appendicular skeleton area of interest </li>
        <li>Area of interest </li>
    </ul>
    </li>
    <li>Magnetic resonance imaging (MRI)
    <ul style="list-style-type: disc;">
        <li>Appendicular skeleton area of interest without intravenous (IV) contrast </li>
        <li>Appendicular skeleton area of interest without and with IV contrast </li>
        <li>Area of interest without IV contrast </li>
        <li>Area of interest without and with IV contrast </li>
    </ul>
    </li>
    <li>Computed tomography (CT)
    <ul style="list-style-type: disc;">
        <li>Appendicular skeleton area of interest without IV contrast </li>
        <li>Appendicular skeleton area of interest without and with IV contrast </li>
        <li>Appendicular skeleton area of interest with IV contrast </li>
        <li>Area of interest without IV contrast </li>
        <li>Area of interest without and with IV contrast </li>
        <li>Area of interest with IV contrast </li>
    </ul>
    </li>
    <li>Ultrasound (US), appendicular skeleton area of interest </li>
    <li>Technetium (Tc)-99m bone scan, whole body </li>
    <li>Fluorine-18-2-fluoro-2-deoxy-D-glucose positron-emission tomography (FDG-PET)/CT, whole body </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Utility of imaging modalities in evaluating patients with chronic extremity join caused by suspected inflammatory arthritis </li>
    <li>Sensitivity, specificity, and diagnostic accuracy of imaging modalities in evaluating chronic extremity joint pain caused by suspected inflammatory arthritis </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Literature Search Summary</span></strong></p>
<p>A literature search was conducted in June 2014 and updated in April 2016 to identify evidence for the <em>ACR Appropriateness Criteria&reg; Chronic Extremity Joint Pain&mdash;Suspected Inflammatory Arthritis</em> topic. Using the search strategies described in the literature search companion (see the "Availability of Companion Documents" field), 5323 articles were found. Thirty-five articles were used in the topic. The remaining articles were not used due to either poor study design, the articles were not relevant or generalizable to the topic, or the results were unclear, misinterpreted, or biased.</p>
<p>The author added 9 citations from bibliographies, Web sites, or books that were not found in the literature search.</p>
<p>One citation is a supporting document that was added by staff.</p>
<p>See also the American College of Radiology (ACR) Appropriateness Criteria&reg; literature search process document (see the "Availability of Companion Documents" field) for further information.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>The literature search conducted in June 2014 and updated in April 2016 identified 35 articles that were used in the topic. The author added 9 citations from bibliographies, Web sites, or books that were not found in the literature search. One citation is a supporting document that was added by staff.</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Definitions of Study Quality Categories</span></strong></p>
<p>Category 1 - The study is well-designed and accounts for common biases.</p>
<p>Category 2 - The study is moderately well-designed and accounts for most common biases.</p>
<p>Category 3 - The study has important study design limitations.</p>
<p>Category 4 - The study or source is not useful as primary evidence. The article may not be a clinical study, the study design is invalid, or conclusions are based on expert consensus.</p>
<p class="Indent">The study does not meet the criteria for or is not a hypothesis-based clinical study (e.g., a book chapter or case report or case series description);</p>
<p class="Indent"><em>Or</em></p>
<p class="Indent">The study may synthesize and draw conclusions about several studies such as a literature review article or book chapter but is not primary evidence;</p>
<p class="Indent"><em>Or</em></p>
<p class="Indent">The study is an expert opinion or consensus document.</p>
<p>Category M - Meta-analysis studies are not rated for study quality using the study element method because the method is designed to evaluate individual studies only. An "M" for the study quality will indicate that the study quality has not been evaluated for the meta-analysis study.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review with Evidence Tables</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>The topic author assesses the literature then drafts or revises the narrative summarizing the evidence found in the literature. American College of Radiology (ACR) staff drafts an evidence table based on the analysis of the selected literature. These tables rate the study quality for each article included in the narrative.</p>
<p>The expert panel reviews the narrative, evidence table and the supporting literature for each of the topic-variant combinations and assigns an appropriateness rating for each procedure listed in the variant table(s). Each individual panel member assigns a rating based on his/her interpretation of the available evidence.</p>
<p>More information about the evidence table development process can be found in the ACR Appropriateness Criteria&reg; Evidence Table Development document (see the "Availability of Companion Documents" field).</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus (Delphi)</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Rating Appropriateness</span></strong></p>
<p>The American College of Radiology (ACR) Appropriateness Criteria (AC) methodology is based on the RAND Appropriateness Method. The appropriateness ratings for each of the procedures or treatments included in the AC topics are determined using a modified Delphi method. A series of surveys are conducted to elicit each panelist's expert interpretation of the evidence, based on the available data, regarding the appropriateness of an imaging or therapeutic procedure for a specific clinical scenario. The expert panel members review the evidence presented and assess the risks or harms of doing the procedure balanced with the benefits of performing the procedure. The direct or indirect costs of a procedure are not considered as a risk or harm when determining appropriateness. When the evidence for a specific topic and variant is uncertain or incomplete, expert opinion may supplement the available evidence or may be the sole source for assessing the appropriateness.</p>
<p>The appropriateness is represented on an ordinal scale that uses integers from 1 to 9 grouped into three categories: 1, 2, or 3 are in the category "usually not appropriate" where the harms of doing the procedure outweigh the benefits; and 7, 8, or 9 are in the category "usually appropriate" where the benefits of doing a procedure outweigh the harms or risks. The middle category, designated "may be appropriate," is represented by 4, 5, or 6 on the scale. The middle category is when the risks and benefits are equivocal or unclear, the dispersion of the individual ratings from the group median rating is too large (i.e., disagreement), the evidence is contradictory or unclear, or there are special circumstances or subpopulations which could influence the risks or benefits that are embedded in the variant.</p>
<p>The ratings assigned by each panel member are presented in a table displaying the frequency distribution of the ratings without identifying which members provided any particular rating. To determine the panel's recommendation, the rating category that contains the median group rating without disagreement is selected. This may be determined after either the first or second rating round. If there is disagreement after the second rating round, the recommendation is "May be appropriate."</p>
<p>This modified Delphi method enables each panelist to articulate his or her individual interpretations of the evidence or expert opinion without excessive influence from fellow panelists in a simple, standardized, and economical process. For additional information on the ratings process see the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">Rating Round Information</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> document.</p>
<p>Additional methodology documents, including a more detailed explanation of the complete topic development process and all ACR AC topics can be found on the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2fQuality-Safety%2fAppropriateness-Criteria" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> (see also the "Availability of Companion Documents" field).</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Criteria developed by the Expert Panels are reviewed by the American College of Radiology (ACR) Committee on Appropriateness Criteria.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The recommendations are based on analysis of the current medical evidence literature and the application of the RAND/UCLA appropriateness method and expert panel consensus.</p>
<p><strong><span style="text-decoration: underline;">Summary of Evidence</span></strong></p>
<p>Of the 45 references cited in the <em>ACR Appropriateness Criteria&reg; Chronic Extremity Joint Pain&mdash;Suspected Inflammatory Arthritis</em> document, all are categorized as diagnostic references, including 5 well-designed studies, 10 good-quality studies, and 9 quality studies that may have design limitations. There are 19 references that may not be useful as primary evidence. There are 2 references that are meta-analysis studies.</p>
<p>Although there are references that report on studies with design limitations, 15 well-designed or good-quality studies provide good evidence.</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Selection of appropriate radiologic imaging procedures for evaluation of patients with chronic extremity joint pain caused by suspected inflammatory arthritis</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><div class="content_para"><p>The false-positive rate for ultrasound (US) in detection of metacarpophalangeal joint erosions has been reported as high as 29%.</p>
<p><strong><span style="text-decoration: underline;">Relative Radiation Level Information</span></strong></p>
<p>Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, both because of organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared to those specified for adults. Additional information regarding radiation dose assessment for imaging examinations can be found in the American College of Radiology (ACR) Appropriateness Criteria&reg; Radiation Dose Assessment Introduction document (see the "Availability of Companion Documents" field).</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>The American College of Radiology (ACR) Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists, and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient's clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient's condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the U.S. Food and Drug Administration (FDA) have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination. </li>
    <li>ACR seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply individual or society endorsement of the final document. </li>
</ul></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Jacobson JA, Roberts CC, Bencardino JT, Appel M, Arnold E, Baccei SJ, Cassidy RC, Chang EY, Fox MG, Greenspan BS, Gyftopoulos S, Hochman MG, Mintz DN, Newman JS, Rosenberg ZS, Shah NA, Small KM, Weissman BN, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® chronic extremity joint pain–suspected inflammatory arthritis. Reston (VA): American College of Radiology (ACR); 2016. 11 p.  [45 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2016</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American College of Radiology - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria&reg;.</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Committee on Appropriateness Criteria, Expert Panel on Musculoskeletal Imaging</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Panel Members</em>: Jon A. Jacobson, MD (<em>Principal Author</em>); Catherine C. Roberts, MD (<em>Panel Chair</em>); Jenny T. Bencardino, MD (<em>Panel Vice-chair</em>); Marc Appel, MD; Erin Arnold, MD; Steven J. Baccei, MD; R. Carter Cassidy, MD; Eric Y. Chang, MD; Michael G. Fox, MD; Bennett S. Greenspan, MD, MS; Soterios Gyftopoulos, MD; Mary G. Hochman, MD, MBA; Douglas N. Mintz, MD; Joel S. Newman, MD; Zehava S. Rosenberg, MD; Nehal A. Shah, MD; Kirstin M. Small, MD; Barbara N. Weissman, MD (<em>Specialty Chair</em>)</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f3097211%2fNarrative%2f" title="ACR Web site">American College of Radiology (ACR) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>ACR Appropriateness Criteria&reg;. Overview. Reston (VA): American College of Radiology; 2015 Oct. 3 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fOverview.pdf" title="ACR Web site">American College of Radiology (ACR) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Literature search process. Reston (VA): American College of Radiology; 2015 Feb. 1 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fLiteratureSearchProcess.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Evidence table development. Reston (VA): American College of Radiology; 2015 Nov. 5 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fEvidenceTableDevelopment.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Topic development process. Reston (VA): American College of Radiology; 2015 Nov. 2 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fTopicDevelopmentProcess.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Rating round information. Reston (VA): American College of Radiology; 2015 Apr. 5 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Radiation dose assessment introduction. Reston (VA): American College of Radiology; 2016. 4 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRadiationDoseAssessmentIntro.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Manual on contrast media. Reston (VA): American College of Radiology; 2016. 128 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2fQuality-Safety%2fResources%2fContrast-Manual" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Procedure information. Reston (VA): American College of Radiology; 2016 May. 2 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fE77E9964C8224151BE6D21A7CE68FEE4.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg; chronic extremity joint pain&mdash;suspected inflammatory arthritis. Evidence table. Reston (VA): American College of Radiology; 2016. 17 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f3097211%2fEvidenceTable%2f" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg; chronic extremity joint pain&mdash;suspected inflammatory arthritis. Literature search. Reston (VA): American College of Radiology; 2016. 2 p. Available from the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f3097211%2fLitSearch%2f" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on January 10, 2017.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>Instructions for downloading, use, and reproduction of the American College of Radiology (ACR) Appropriateness Criteria&reg; may be found on the <a href="/web/20180712202903/https://www.guideline.gov/Home/Disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2fQuality-Safety%2fAppropriateness-Criteria%2fTermsConditions" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712202903im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712202903/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712202903/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712202903/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712202903/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712202903/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712202903/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712202903/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712202903/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712202903/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712202903/https://www.guideline.gov/disclaimer?id=50494&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712202903/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712202903/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712202903/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712202903/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712202903/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712202903/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712202903/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712202903/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712202903/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712202903/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712202903/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712202903/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712202903/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712202903/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712202903im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712202903/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712202903/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712202903js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712202903js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 20:29:03 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:13:36 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 531.908 (3)
  esindex: 0.011
  captures_list: 551.275
  CDXLines.iter: 14.281 (3)
  PetaboxLoader3.datanode: 55.843 (4)
  exclusion.robots: 0.274
  exclusion.robots.policy: 0.257
  RedisCDXSource: 0.864
  PetaboxLoader3.resolve: 450.328 (3)
  load_resource: 122.627
-->